Cvi Holdings, LLC Mannkind Corp Transaction History

Cvi Holdings, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$1.56 - $2.08 $2.82 Million - $3.76 Million	-1,808,190 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.94 - $2.21 $1.7 Million - $4 Million	1,808,190 New	1,808,190 $3.16 Million
Q1 2020 May 15, 2020	SELL	$0.84 - $1.76 $3.11 Million - $6.52 Million	-3,705,310 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.14 - $1.49 $3.7 Million - $4.83 Million	3,244,170 Added 703.51%	3,705,310 $4.78 Million
Q1 2019 May 15, 2019	SELL	$1.14 - $2.25 $11.7 Million - $23.1 Million	-10,254,940 Reduced 95.7%	461,140 $908,000
Q4 2018 Feb 14, 2019	BUY	$1.02 - $2.05 $10.9 Million - $22 Million	10,716,080 New	10,716,080 $11.4 Million

243

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.57B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Cvi Holdings, LLC, based on Form 13F filings with the SEC.

Stay updated on Cvi Holdings, LLC with notifications on news.